Daiwa Securities Group’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Sell |
45
-1
| -2% | – | ﹤0.01% | 1324 |
|
|
2025
Q1 | $0 | Hold |
46
| – | – | ﹤0.01% | 1303 |
|
|
2024
Q4 | $1K | Hold |
46
| – | – | ﹤0.01% | 1257 |
|
|
2024
Q3 | $1K | Hold |
46
| – | – | ﹤0.01% | 1251 |
|
|
2024
Q2 | $1K | Hold |
46
| – | – | ﹤0.01% | 1283 |
|
|
2024
Q1 | $2K | Hold |
46
| – | – | ﹤0.01% | 1264 |
|
|
2023
Q4 | $2K | Hold |
46
| – | – | ﹤0.01% | 1265 |
|
|
2023
Q3 | $1K | Hold |
46
| – | – | ﹤0.01% | 1252 |
|
|
2023
Q2 | $3K | Hold |
46
| – | – | ﹤0.01% | 1212 |
|
|
2023
Q1 | $2K | Hold |
46
| – | – | ﹤0.01% | 1211 |
|
|
2022
Q4 | $3K | Hold |
46
| – | – | ﹤0.01% | 1191 |
|
|
2022
Q3 | $7K | Hold |
46
| – | – | ﹤0.01% | 1139 |
|
|
2022
Q2 | $6K | Buy |
46
+11
| +31% | +$1.44K | ﹤0.01% | 1152 |
|
|
2022
Q1 | $4K | Hold |
35
| – | – | ﹤0.01% | 1191 |
|
|
2021
Q4 | $5K | Buy |
+35
| New | +$5K | ﹤0.01% | 1191 |
|